The cost-effectiveness of strategies in coronary artery disease.

about

Impact of Physician-Coordinated Intensive Follow-Up on Long-Term Medical Costs in Patients with Unstable Angina Undergoing Percutaneous Coronary Intervention.

P2860

Q37719015-9F91C6FC-9735-4E8A-AEF0-0C6AB28BEDFE

P2860

The cost-effectiveness of strategies in coronary artery disease.

Item

http://www.wikidata.org/entity/Q38255595

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

The cost-effectiveness of strategies in coronary artery disease.

@en

type

Item

label

The cost-effectiveness of strategies in coronary artery disease.

@en

prefLabel

The cost-effectiveness of strategies in coronary artery disease.

@en

P1476

The cost-effectiveness of strategies in coronary artery disease.

@en

P2093

Paulo Cury Rezende

http://www.w3.org/2001/XMLSchema#string

Thiago Luis Scudeler

http://www.w3.org/2001/XMLSchema#string

Whady Hueb

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in published cost effectiveness studies: systematic review.

Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost-effectiveness analysis

The value of clopidogrel versus aspirin in reducing atherothrombotic events: the CAPRIE study

Modelling the long term cost effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UK

Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients

Strategies for multivessel revascularization in patients with diabetes

Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators

Fractional flow reserve versus angiography for guiding percutaneous coronary intervention

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

Cost-effectiveness of drug-eluting stents in a US Medicare setting:a cost-utility analysis with 3-year clinical follow-up data.

P304

805-813

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1586/14737167.2014.957681

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25269456

http://www.w3.org/2001/XMLSchema#string

The cost-effectiveness of strategies in coronary artery disease.

about

P2860

P2860

The cost-effectiveness of strategies in coronary artery disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698